SUMMARY

Adaptive Foxp3
+ regulatory T (Treg) cells develop during induction of mucosal tolerance and after immunization. Large numbers of Foxp3 + T cells have been found in inflamed tissues. We investigated the role of adaptive Foxp3 + Treg cells in mucosal tolerance and in chronic allergic lung inflammation. We used two strains of mice that are devoid of naturally occurring Treg cells; one is capable of generating adaptive Foxp3 + Treg cells upon exposure to antigen, whereas the other is deficient in both naturally occurring and adaptive Foxp3 + Treg cells. We found that adaptive Foxp3 + Treg cells were essential for establishing mucosal tolerance and for suppressing IL-4 production and lymphoid neogenesis in chronic inflammation, whereas IL-5 production and eosinophilia could be controlled by Foxp3-independent, IFN-g-dependent mechanisms. Thus, whereas adaptive Foxp3 + Treg cells regulate sensitization to allergens and the severity of chronic inflammation, IFN-g-producing cells can play a beneficial role in inflammatory conditions involving eosinophils.
INTRODUCTION
Immunological tolerance to inhaled environmental allergens protects individuals from developing pathological responses in the airways and lungs. Failures in the mechanisms of tolerance lead to the sensitization to allergens and to inflammatory reactions such as allergic asthma. Allergic asthma is characterized by production of T helper 2 (Th2) cytokines, IgE antibodies, eosinophilic lung inflammation, bronchial hyper-responsiveness, and lung remodeling (Wills-Karp, 1999) (Cohn et al., 2004) .
Th2 cell-mediated allergic reactions can be prevented by CD4 + regulatory T cells (Curotto de . Naturally occurring CD4 + Treg cells express Foxp3 (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003) , develop in the thymus, and migrate to the peripheral lymphoid organs (Shevach et al., 2006 Mucida et al., 2005) . In vitro, naive T cells can convert to Foxp3
+ cells by stimulation in the presence of TFG-b and IL-2 (Chen et al., 2003; Zheng et al., 2007) . In mice and humans, deficiency in Foxp3 causes spontaneous autoimmunity with multi-organ inflammation and early death (Bennett et al., 2001; Chatila et al., 2000) . Foxp3 deficiency also leads to increased atopy (Lin et al., 2005) .
Previously, we studied T cell differentiation during oral-tolerance induction in mice that harbor a monoclonal CD4 + T population specific for chicken ovalbumin (OVA) and that lack naturally occurring Treg cells. We found that OVA-specific Foxp3 + Treg cells were induced upon addition of OVA to the drinking water. Tolerant mice were protected against immunization with OVA in adjuvants, whereas naive mice became sensitized; they developed a Th2 response, IgE antibodies, and allergic inflammation (Mucida et al., 2005) . Intriguingly, OVA-specific Foxp3 + Treg cells were also induced, alongside Th2 cells, by immunization of naive mice with adjuvants; the role of these immunizationinduced Treg cells is not clear because they obviously do not prevent the primary allergic response. Although the name ''adaptive'' Treg cells is mostly used in reference to Foxp3-negative regulatory T cells such as Tr1 cells (Levings et al., 2005; Vieira et al., 2004) (Ruprecht et al., 2005; Saruta et al., 2007; Sasaki et al., 2007; Smyth et al., 2007; van Amelsfort et al., 2004) . It is unclear whether in chronic inflammation these Treg cells are unable to carry out their function, whether they are overwhelmed or neutralized, or even whether they contribute to the pathology, for instance by secreting TGF-b that is important in fibrosis. In acute allergic inflammation, antibody depletion of CD25 + cells had a worsening effect in one of two mouse strains tested (Lewkowich et al., 2005) , and a study showed that the number of Treg cells correlated inversely with the severity of allergic inflammation in a rat model of asthma (Strickland et al., 2006) . Like all monoclonal T cell receptor-transgenic mice described thus far, T-Bmc lack naturally occurring Foxp3 + Treg cells (Mucida et al., 2005; Shen et al., 2005) . We showed previously that the oral administration of OVA to T-Bmc mice resulted in immunological tolerance, which correlated with the induction of antigen-specific adaptive Foxp3 + CD25 + Treg cells. To ensure that the observed conversion of Foxp3 À into Foxp3 + cells in OVA-fed T-Bmc mice was not an artifact caused by the very high frequency of OVA-specific T cells in T-Bmc mice, we transferred bone marrow from T-Bmc mice to wild-type BALB/c recipient mice. In the resulting chimeras, the proportion of OVA-specific Rag-deficient T cells was less than 2% of the T cells, and the vast majority of the T cells were polyclonal wild-type cells of host origin. Importantly, in these chimeras we also observed the ''de novo'' expression of Foxp3 in donor-derived OVA-specific cells after OVA feeding, whereas no conversion occurred in controls that did not received OVA ( Figure S1 in the Supplemental Data).
Foxp3-deficient scurfy mice develop a fulminating inflammatory disease and die at about the age of weaning (Kanangat et al., 1996) . To study the role of adaptive Foxp3 + regulatory T cells without the influence of the imminent inflammatory disease, we crossed scurfy mice with T-Bmc mice, whose monoclonal T and B lymphocytes do not recognize self-or environmental antigens. In the absence of deliberate antigen exposure, lymphocytes in the T-Bmc Foxp3 sf mice had a naive phenotype, and dendritic cells did not show signs of spontaneous activation ( Figure S2 ). ). We first tested whether administration of OVA by oral or intranasal mucosal routes to T-Bmc Foxp3 sf mice would prevent an allergic response to subsequent immunization with antigen (OVA-HA) in alum ( Figure 1A ). To determine whether the mice had become sensitized and capable of developing allergic lung inflammation, OVA-HA was subsequently instilled by intranasal route ( Figure 1A) .
T-Bmc mice carrying the mutated Foxp3 gene failed to develop mucosa-induced tolerance to OVA, as demonstrated by the high IgE levels in sera of T-Bmc Foxp3 sf mice that received oral or intranasal OVA before immunization ( Figure 1B Figure 1B ). Similar conclusions were reached with other inflammation readouts. Cells obtained from broncho-alveolar lavage (BAL) of T-Bmc Foxp3 sf mice pretreated with oral or intranasal OVA before immunization produced IL-4, whereas IL-4 production was suppressed in T-Bmc Foxp3 wt mice ( Figure 1C ). Quantification of eosinophils in the BAL revealed intense eosinophilic inflammation in Foxp3 sf mice but not in T-Bmc Foxp3 wt mice administered oral or nasal OVA before immunization ( Figure 1D ). The failure of mucosal tolerance in T-Bmc Foxp3 sf mice was also illustrated by the unrestrained development of germinal centers and class switching in spleen and lymph nodes ( Figure S3 ).
Foxp3 expression was detected in BAL cells of tolerant and allergic Foxp3 wt mice, demonstrating that Foxp3 + Treg cells were induced after antigen treatment and localized to the airways after intranasal challenge ( Figures 1E and 1F ). The induction of OVAspecific adaptive Foxp3 + Treg cells and immunological tolerance in this model did not require the thymus in light of the fact that it occurred in thymectomized animals ( Figure S4 ). To confirm that the phenotype of the T-Bmc Foxp3 sf mice was solely the consequence of their T cell defect, we transferred naive OVA-specific T cells from Foxp3 wt mice to T-Bmc Foxp3 sf mice. The recipient mice were subsequently administered OVA in drinking water for 5 days and then immunized with OVA-HA in alum. Two weeks after immunization, the concentration of IgE antibodies in serum was determined. As anticipated, the transfer of T cells from T-Bmc Foxp3 wt mice could complement the tolerance defect of T-Bmc Foxp3 sf mice ( Figure S5 ).
Altogether, these experiments demonstrate that Foxp3-expressing T cells are essential for extablishing immunological tolerance through the intestine and the airways and that other (Foxp3-independent) tolerance mechanisms play little or no role.
Adaptive Foxp3
+ Treg Cells Display High Basal
Proliferation and a Rapid Increase of Inflammation
The observation that Treg cells are induced by immunization (Mucida et al., 2005) , and that they represent a higher proportion of CD4 + cells in the inflamed airways than in the lymphoid organs T-Bmc mice were immunized with OVA-HA in alum by intraperitoneal route, and 2-3 weeks later they received intranasal + cells became more prominent; they had increased 13-fold in the lungs and more than 100-fold in the BAL by the second day after intranasal challenge. In comparison, CD4 cells increased 4-fold in the lungs and 14-fold in the BAL, and the increase in total cells was even lower (Figure 2A ). Thus, there was an enrichment of Treg cells in lungs and airways as the inflammation progressed.
Immunity
Adaptive Foxp3 + Treg Cells in Allergic Inflammation
Comparison of the frequencies of the different CD4 + T cell subsets in lungs, airways, and lymphoid organs showed that, on average, inflamed lungs and airways contained the highest percentage of Foxp3 + cells ( Figure 2B ). It was interesting to observe the relative paucity of Foxp3 + cells within the BAL population from immunized mice that had not been administered intranasal antigen. In these mice, (indicated as ''0'' in Figure 2 ), the percentage of Foxp3 + within CD4 + cells was much lower in the BAL than in the lungs, LN, or spleen. This is further illustrated in Figure 2C by the analysis of BAL, lung, and spleen CD4 + cells from Foxp3gfp.KI reporter T-Bmc mice. After intranasal challenge, the percentage of GFP + cells increased dramatically in the BAL, consistent with the results shown in Figure 2B .
BAL CD4 + cells in immunized but unchallenged mice had an activated and memory CD25 + CD45RB low phenotype ( Figure 2D ). It has been known for a long time that antigen administration through mucosal routes results in immunological tolerance. We reported that oral tolerance in T-Bmc Foxp3 wt mice correlated with the generation of Foxp3 + Treg cells (Mucida et al., 2005) .
We then asked whether the administration of oral OVA per se would induce the differentiation of CD4 + Th effector cells when Foxp3 + Treg cells could not be generated. To this end, we fed OVA to T-Bmc mice with either wild-type or scurfy Foxp3 genes and studied the activation and effector functions of their mesenteric LN T cells ( Figure 3A ). Two days after the oral OVA treatment, the early activation marker CD69 was similarly upregulated in T cells from T-Bmc Foxp3 wt or T-Bmc Foxp3 sf mice (47% and 44% of CD69 + cells among OVA-specific T cells, respectively). Far fewer OVA-specific T cells expressed CD25 or CD103 at the same time point ( Figure 3B ). A population of OVA-specific T cells coexpressing Foxp3, CD25, and CD103 was induced in Foxp3 wt mice but not in Foxp3 sf mice ( Figure 3B) Figure 4A ). We observed marked differences in lung inflammation between wild-type mice and those carrying scurfy Foxp3 genes. H&E-stained lung sections showed dense perivascular and peribronchial cellular infiltrates in chronically challenged T-Bmc Foxp3 sf mice, whereas a greatly reduced inflammatory load was observed in Foxp3-competent T-Bmc mice ( Figure 4B ). In fact, chronically challenged T-Bmc Foxp3 wt mice had less lung inflammation than mice with acute inflammation. In contrast, in T-Bmc Foxp3 sf mice the degree of inflammation increased as the number of exposures to antigen increased ( Figure 4B ).
The analysis of lung-infiltrating cells showed that chronically challenged T-Bmc Foxp3 sf mice had three to four times more cells infiltrating the lungs than Foxp3 wt mice ( Figure 4C ). Figure 4D ), even though both mice strains generated comparable hyper-IgE responses in acute phase.
The differences in IL-4 and IgE production in chronically challenged mice were confirmed through Q-PCR analysis of RNA expression in BAL cells, lungs, and draining LN ( Figure 4E ). We included samples from immunized mice with acute inflammation to examine the acute-to-chronic progression. We also analyzed the expression of IL-10, a cytokine produced by Th2 and Tr1 cells; IL-33, a cytokine produced by lung epithelial cells that promotes Th2 responses (Schmitz et al., 2005) ; and Fc3RI, which is expressed by mast cells and basophils. In T-Bmc mice with intact Foxp3 genes, the IL-4 mRNA production decreased significantly from the acute to the chronic phase in thoracic LN and less substantially in BAL cells and lungs. In contrast, IL-4 mRNA was upregulated several-fold from the acute to the chronic phase in T-Bmc Foxp3 sf mice ( Figure 4E ). A similar pattern of expression was observed for IL-10. A large increase in mRNA for Fc3RI was observed in chronically challenged T-Bmc Foxp3 sf mice, indicating an increased number of mast cells and/or basophils. A much lower increase in Fc3RI mRNA was observed in chronically challenged mice with adaptive Foxp3 Treg cells ( Figure 4E ). Analysis of IgE transcripts in lungs and draining LN yielded a rather similar result. Production of IL-33 mRNA was also sustained in Treg-deficient chronically challenged mice, whereas it was suppressed in chronically challenged mice capable of generating adaptive Foxp3 + Treg cells ( Figure 4E ). From these data we conclude that, in situations of chronic antigen exposure, adaptive Foxp3 + Treg cells have an important role in reducing IL-4 production, IL-4 mediated pathology, and overall inflammation in the lung.
Adaptive Foxp3 + Treg Cells Control Formation of Ectopic Organized Lymphoid Tissue
A feature of many chronic inflammatory diseases is the ectopic development of organized lymphoid tissue with defined T and B cell areas and germinal centers (Aloisi and Pujol-Borrell, 2006; Drayton et al., 2006; Moyron-Quiroz et al., 2007) . We therefore investigated whether the dense lymphoid aggregates found in the lungs of chronically challenged T-Bmc Foxp3 sf mice showed lymphoid tissue-organization. Indeed, lymphoid aggregates with distinct T and B cell areas, including GL7 + germinal centers, could be clearly identified in frozen lung sections from T-Bmc Foxp3 sf mice ( Figure 5A ). Furthermore, large numbers of IgE + and IgG1 + cells localized to the lymphoid aggregates, suggesting in situ class switching in the lungs ( Figure S8 ). Thus, in mice that lack naturally occurring as well as adaptive Foxp3 + Treg cells, chronic antigen stimulation through the airways leads to an abundance of organized lymphoid tissue in the lungs. Ectopic lymphoid tissue in the lungs was much less abundant in mice able to generate adaptive Foxp3 + Treg cells. Given the amplified inflammation observed in T-Bmc Foxp3 sf mice compared to T-Bmc Foxp3 wt mice, we studied whether lung remodeling, a feature of chronic asthma, was increased in mice deficient in Foxp3. We observed severe smooth-muscle hypertrophy in blood vessels and, to a lesser degree, in the bronchia in T-Bmc Foxp3 sf mice but observed much-less-intense Figure 6A ). It is worth noting that because the first immunization was intraperitoneal ( Figure 4A ), during the acute response we also found OVAspecific Th2 cells in spleen and mLN of T-Bmc 
Foxp3-Independent Control of Eosinophilia
We next assessed IL-5 production and eosinophilia during the acute and chronic phases in mice able or unable to generate adaptive Foxp3 + Treg cells. We observed more than a 90% reduction of eosinophil numbers in the BAL of chronically challenged T-Bmc Foxp3 wt mice compared with BAL from acutephase mice ( Figure 7A ). Chronically challenged T-Bmc Foxp3 sf mice also showed a significant reduction in eosinophilia compared to acute-phase mice, although this reduction (75%) was less pronounced than in T-Bmc Foxp3 wt mice. Essentially the same results were obtained by Q-PCR analysis with eosinophil peroxidase ( Figure 7B ). Thus, eosinophilia can be controlled to a significant extent in the absence of both naturally occurring and adaptive Foxp3 + Treg cells.
Consistent with the reduced eosinophilia, we found that IL-5 mRNA expression was greatly reduced in BAL and thoracic LN cells of chronically challenged mice irrespective of the presence or absence of adaptive Foxp3 + T cells ( Figure 7B ). Intracellular staining of IL-5 in lung-infiltrating T cells also showed marked reduction in the chronic phase compared to the acute phase ( Figure 7C ). Thus, suppression of eosinophilia in chronically challenged mice is probably secondary to the suppression of IL-5 production and occurs even in the complete absence of Foxp3 + Treg cells.
In order to investigate the mechanism of Foxp3 + Treg-independent reduction in eosinophilia, we focused on IFN-g. We showed previously that the presence of small amounts of IFN-g were important in reducing the amount of IL-5 production by Th2 cells ). It has also been shown that IFN-g suppressed eosinophilia during acute allergic inflammation in sensitized BALB/c mice (Iwamoto et al., 1993) . If IFN-g is critical for the reduction in eosinophils during chronic lung inflammation in a Foxp3 + Treg-independent fashion, neutralization of IFN-g should maintain the eosinophilia in Foxp3 sf and Foxp3 wt mice. Indeed, injection of anti-IFN-g antibody weekly into T-Bmc Foxp3 wt or T-Bmc Foxp3 sf mice exposed to chronic intranasal antigen led to a 600% increase in the number of eosinophils in the BAL ( Figure 7D ). These results support a role for IFN-g in the Foxp3-independent control of eosinophilia. (Lafaille et al., 1994; Olivares-Villagomez et al., 1998) and, much later, described the absence of Foxp3 + T cells in these mice (Shen et al., 2005) . The lack of thymic-derived Foxp3 + T cells in TCR Tg Rag À/À mice was fundamental to the demonstration of in vivo peripheral conversion of CD4 + Foxp3 À cells into functional CD4 + Foxp3 + Treg cells (Apostolou and von Boehmer, 2004) (Cobbold et al., 2004) (Curotto de Lafaille et al., 2004; Mucida et al., 2005) .
DISCUSSION
Although they solved one problem, the TCR Tg Rag À/À experimental systems could be criticized because, by necessity, they harbored a monoclonal T cell repertoire. It was thus important that we establish that the same principles of adaptive Foxp3 + Treg induction applied when the T cells derived from TCR Tg Rag À/À mice were a small minority in the context of wild-type mice. Therefore, the experimental system used in this manuscript reproduces the mucosal-tolerance-inductive mechanisms that operate in wild-type mice with full lymphocyte repertoires. A second issue in the development of the experimental system was to specifically eliminate adaptive Foxp3 + regulatory T cells. mechanisms of mucosal tolerance did not contribute to the reduction of Th2-mediated responses. Given the fact that other T cells, such as Th3 cells (Fukaura et al., 1996) , have been shown to be important in oral tolerance, it is likely that these cells operate in the same pathway as adaptive Although oral OVA per se did not induce tolerance in Foxp3-deficient T-Bmc mice, it did not induce effector functions either; no increase in the Th1, Th2, or Th17 cytokines was observed. This was striking in consideration of the fact that the mesenteric LN T cells upregulated CD69, an indication of antigen-mediated activation. Because TGF-b is required for the development of both adaptive Treg and Th17 cells, it was postulated that there is a reciprocal pathway leading to either Th17 or Treg cells (Bettelli et al., 2006) . Thus, a higher percentage of Th17 cells could have been expected in the absence of Foxp3, but this was not the case. Our data are consistent with the idea that different intestinal microenvironments give rise to Th17 cells and Treg cells (Coombes et al., 2007; Denning et al., 2007; Mucida et al., 2007; Sun et al., 2007) and support the view that, in the absence of adjuvant factors, oral antigen is presented in a microenvironment that can only give rise to Treg cells.
We studied the proliferation and accumulation of Treg cells during the onset of lung inflammation. We observed that adaptive Foxp3 + T cells had a higher proliferation rate in vivo than non-Treg CD4 + cells of identical specificity. Other laboratories have observed robust proliferation of Treg cells in vivo (Annacker et al., 2001; Klein et al., 2003; Walker et al., 2003 diated a marked reduction of cytokine production in lungs and lymphoid organs and a reduction of cellular inflammation in the lungs. Interestingly, the resolution of lung inflammation in immunized wild-type BALB/c mice chronically exposed to antigen follows a similar pattern (Shinagawa and Kojima, 2003 ; also data not shown). We called this phenomenon ''post-sensitization regulation'' because it occurs after the onset of Th2 inflammation. In contrast, mucosal tolerance prevents the development of effector cytokine-producing Th cells altogether. Post-sensitization regulation in the chronic phases also involved decreased IL-5 production and eosinophilia, but this occurred in mice that developed Foxp3 + Treg cells as well as in Foxp3-deficient mice. We found that the decreased eosinophilia was dependent on IFN-g; antibody neutralization of IFN-g restored high eosinophil numbers in both mouse strains. Our laboratory showed that IFN-g selectively regulates IL-5 production in differentiating Th2 cells without interfering with IL-4 production . Thus, in chronically challenged mice with no Foxp3 + Treg cells, IFN-g might affect newly differentiating Th2 cells by suppressing IL-5 production while maintaining IL-4 production. Another possible explanation for the dissociation between IL-4 and IL-5 production in the chronically challenged T-Bmc Foxp3 sf mice is that many of the IL-4-producing cells in inflamed tissue are cells that would have become Foxp3 + if they had a normal Foxp3 gene (Williams and Rudensky, 2007) . Finally, it is also possible that the cellular sources of IL-4 and IL-5 change from the acute to the chronic phases and that cells other than Th2 cells, such as mast cells and basophils, make a greater contribution to IL-4 production at the chronic stages. (Korn et al., 2007) was backcrossed to the T-Bmc mice in a BALB/ c background for four generations. Oral and airway tolerance to chicken ovalbumin (OVA) were induced as described (Mucida et al., 2005) . For immunization, mice were injected with 100 mg OVA-HA in 1 mg of alum by intraperitoneal route. To induce acute lung inflammation, we administered 10 mg of OVA-HA by intranasal route three times. To determine T cell proliferation rates, we injected mice with 3 mg of BrdU by combined intraperitoneal and intravenous routes 6 hr before analysis. To induce chronic lung inflammation, we administered 10 mg of OVA-HA twice a week for 8 weeks. To neutralize IFN-g, we injected immunized mice with 1 mg of the antibody XMG.1 by intraperitoneal route once a week, beginning one day before the first intranasal treatment. BAL collection and analysis and lung histology were performed as described (Mucida et al., 2005) . All mouse procedures were approved by the New York University Institutional Animal Care Use Committee.
Mononuclear Cell Isolation and Flow Cytometry BAL, LN, and spleen mononuclear cell suspensions were prepared as described (Curotto de Mucida et al., 2005) . To obtain infiltrating lung cells, we digested lungs from perfused mice with liberase blendzyme (Roche) and purified the infiltrating cells over 38% Percoll (Amersham Biosciences). Cytokine-producing cells were detected by flow cytometry after exvivo stimulation with PMA and Ionomycin. Staining of Foxp3, BrdU, and cytokines was performed on fixed and permeabilized cells. Data were acquired in a FACS Calibur (BD Biosciences) and analyzed with FlowJo software (Tree Star).
Quantitative PCR Analysis RNA was extracted with TRIzol (Invitrogen). cDNA synthesis and real-time PCR were performed by standard procedures. Expression values were normalized to b-actin. Most oligonucleotide sequences have been described previously (Curotto de Lafaille et al., 2004; Erazo et al., 2007; Ivanov et al., 2006; Mucida et al., 2005) . Additional sequences are provided in the Supplemental Data.
Lung Immunohistology
Frozen lung sections were fixed with acetone, blocked, stained, and analyzed as described (Erazo et al., 2007) . 
Statistical Analysis
